![]() | Up a level |
Journal Article
Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortman, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Tabatabai, Ghazaleh, Ringel, Florian, Schmidt-Graf, Friederike, Brehmer, Stefanie, Weyerbrock, Astrid, Bullinger, Lars, Vajkoczy, Peter, Vatter, Hartmut, Schaefer, Niklas, Kebir, Sied, Weller, Johannes, Stummer, Walter, Simon, Matthias, Keil, Vera ORCID: 0000-0001-8699-3506, Nelles, Michael, Fimmers, Rolf, Pietsch, Torsten, Hattingen, Elke, Coch, Christoph and Glas, Martin
(2017).
PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial.
Neuro-Oncology, 19.
S. 13 - 15.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Herrlinger, Ulrich, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter
ORCID: 0000-0003-3894-5053, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schaefer, Niklas, Kebir, Sied, Weller, Johannes
ORCID: 0000-0001-5818-5392, Schaub, Christina, Stummer, Walter, Tonn, Joerg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
ORCID: 0000-0002-6171-634X, Weller, Michael, Fimmers, Rolf, Schmid, Matthias
ORCID: 0000-0002-0788-0317, Hattingen, Elke
ORCID: 0000-0002-8392-9004, Pietsch, Torsten, Coch, Christoph and Glas, Martin
(2019).
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet, 393 (10172).
S. 678 - 689.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Weller, Johannes
ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos
ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich
(2019).
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J. Neuro-Oncol., 144 (3).
S. 501 - 510.
NEW YORK:
SPRINGER.
ISSN 1573-7373
Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin
(2018).
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
J. Cancer Res. Clin. Oncol., 144 (8).
S. 1581 - 1590.
NEW YORK:
SPRINGER.
ISSN 1432-1335
Schliesser, Maximilian Georg, Claus, Rainer ORCID: 0000-0003-2617-8766, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter
ORCID: 0000-0003-3894-5053, Schramm, Johannes, Sahm, Felix
ORCID: 0000-0001-5441-1962, Weiss, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick
ORCID: 0000-0003-3897-214X, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Hartmann, Christian, Pietsch, Torsten, Felsberg, Joerg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
ORCID: 0000-0002-5863-540X, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
ORCID: 0000-0002-4746-887X, Weller, Michael
ORCID: 0000-0002-1748-174X, Plass, Christoph and Wick, Wolfgang
ORCID: 0000-0002-6171-634X
(2016).
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget, 7 (50).
S. 82028 - 82046.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Wick, Wolfgang ORCID: 0000-0002-6171-634X, Roth, Patrick, Hartmann, Christian, Hau, Peter
ORCID: 0000-0003-3894-5053, Nakamura, Makoto, Stockhammer, Florian
ORCID: 0000-0002-0525-5956, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Pietsch, Torsten, Happold, Caroline, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael
ORCID: 0000-0002-4746-887X, von Deimling, Andreas
ORCID: 0000-0002-5863-540X, Meisner, Christoph, Wiestler, Benedikt and Weller, Michael
ORCID: 0000-0002-1748-174X
(2016).
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, 18 (11).
S. 1529 - 1538.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866